$ACI

Albertsons Stock (ACI) Slumps as Boss Announces Full Business Review and Annual Guidance Delay

Albertsons (ACI) shares fell after CEO Susan Morris announced a full business review and delayed annual guidance. Q2 earnings per share beat estimates at $0.36, but revenue declined slightly to $18.89B. Pharmacy and digital sales grew, while net income dropped to $51.5M. The company also seeks $9B from Kroger over a failed merger. Analysts have a Hold consensus with a $13 price target.

Original reporting
Published Oct 13, 2026, 1:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 2:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ACI
Bearish
high confidence
Mentioned
$ACI
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$ACIBearishMed
01

Why it matters

The mixed signal may trigger short‑term volatility while longer‑term investors watch for operational improvements.

02

Market read

Earnings beat tempered by guidance delay creates near‑term downside risk.

03

What to watch

Potential upside from digital sales growth and fuel revenue offsets.

Relevance 7/10Novelty 7/10Timing: today

Background

Albertsons (ACI) announced Q2 results, beat EPS expectations, but postponed its annual outlook pending a business review.

Company-level read

Ticker impact

$ACIBearishHigh confidence
Context

Albertsons reported Q2 earnings with a beat on EPS but delayed its annual guidance, indicating operational concerns.

Expected impact

downward pressure as investors reassess outlook

Evidence & confidence

Guidance delays often trigger short-term sell‑offs despite earnings beats.

Market effects

Grocery sector may see heightened scrutiny on cost‑control initiatives.

U.S. consumer‑discretionary sentiment could soften.

Limited to U.S. retail investors.

Counterpoint

The earnings beat and strong pharmacy sales could support a rebound if the review yields cost cuts.

Key entities

  • Albertsons Companies

    U.S. grocery retailer reporting earnings and guidance delay.

Related articles

$ACIMed

Albertsons launches business review; seeks over $8B from Kroger

Albertsons reported Q2 revenue of $18.89B, down 0.1% YoY, and adjusted net income fell 28% to $179M. The company launched a business review to cut costs and improve performance, withdrawing its full-year guidance. Albertsons also seeks over $8B in damages from Kroger for allegedly failing to secure regulatory approval for their failed merger.

$ACIMedAI 8/10

Albertsons seeks $8B from Kroger over failed merger

Albertsons is suing Kroger for $8B, including a $600M break-up fee, over the failed merger, claiming Kroger acted in bad faith. Kroger disputes the claim, stating Albertsons hindered regulatory approval. The trial is set for October 19, 2024. Albertsons seeks compensation for shareholder losses and taxes. The merger, valued at $24.6B, collapsed in December 2024.

$ACIMed

What's Going On With Albertsons Stock Tuesday? - Albertsons Companies (NYSE:ACI)

Albertsons (ACI) stock rose after reporting Q2 2026 earnings of $0.36/share, beating estimates of $0.33. Revenue fell 0.1% YoY to $18.895B but exceeded expectations. Margins narrowed due to higher costs, while debt increased. The company withdrew its full-year outlook amid a business review and plans to announce a turnaround strategy later. Executives emphasized the need for cost cuts, better pricing, and operational improvements.

$ACIMedAI 8/10

Albertsons Companies Q2 Earnings Call Highlights

Albertsons (ACI) reported Q2 earnings, highlighting a 1.5% decline in core business sales and a 26.8% gross margin. The company plans to accelerate cost savings, including centralized buying and potential headcount reductions, aiming for $2B in savings over three years. Albertsons generated $1.2B in operating cash flow and repurchased $175M in shares. Management is reviewing its portfolio and expects to provide an updated strategy and outlook by Q4.